Peripheral sector news—fascinating nonetheless
Stem cell therapy is a hot sector. The newsflow in the space remains constant. IR awareness and analyst coverage will attract a lot of new eyeballs to Hemostemix. It's just a matter of time before the valuation becomes more normalized and respectable.
“The umbilical cord contains progenitor stem cells, or mesenchymal stem cells, that can be expanded and provide therapeutic doses for over 10,000 patients from a single umbilical cord. It’s a unique resource of cells that are under investigation for their possible use in cell therapy applications, anytime you have to modulate immune response or inflammatory response,” he said. “We’ve been studying them with our collaborators in China for more than 10 years in Type 1 Diabetes, and there are currently over 260 clinical studies listed in clinicaltrials.gov for treatment of other autoimmune diseases.”